Northern Trust Corp Point Biopharma Global Inc. Transaction History

Northern Trust Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.67 - $9.71 $138,949 - $202,278	20,832 Added 2.6%	822,026 $5.48 Million
Q2 2023 Aug 11, 2023	BUY	$6.86 - $10.86 $308,274 - $488,026	44,938 Added 5.94%	801,194 $7.26 Million
Q1 2023 May 15, 2023	BUY	$6.78 - $8.1 $216,587 - $258,754	31,945 Added 4.41%	756,256 $5.5 Million
Q4 2022 Feb 13, 2023	BUY	$5.72 - $9.78 $466,191 - $797,089	81,502 Added 12.68%	724,311 $5.28 Million
Q3 2022 Nov 14, 2022	SELL	$7.24 - $10.31 $14,581 - $20,764	-2,014 Reduced 0.31%	642,809 $4.97 Million
Q2 2022 Aug 12, 2022	BUY	$5.6 - $9.5 $2.84 Million - $4.83 Million	507,941 Added 371.08%	644,823 $4.39 Million
Q1 2022 May 13, 2022	SELL	$5.46 - $8.13 $13,300 - $19,804	-2,436 Reduced 1.75%	136,882 $1.09 Million
Q4 2021 Feb 08, 2022	BUY	$4.83 - $9.75 $45,561 - $91,971	9,433 Added 7.26%	139,318 $780,000
Q3 2021 Nov 15, 2021	BUY	$7.42 - $11.26 $963,746 - $1.46 Million	129,885 New	129,885 $999,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.